| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide a Silodosin in a novel crystalline form. <P>SOLUTION: There is provided Silodosin in novel crystalline forms of δ and ε. There are provided a method for preparing Silodosin by using a specific solvent and a poor solvent, and a use of the Silodosin δ form for preparing Silodosin β form and Silodosin ε form, and pharmaceutical compositions comprising an effective amount of crystalline form of δ and/or ε form of Silodosin. <P>COPYRIGHT: (C)2012,JPO&INPIT |
